HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

3SBIO

22.700

+0.7503.42%

Volume:31.84M

Turnover:705.90M

Market Cap:54.46B

PE:24.04

High:23.100

Open:22.250

Low:21.450

Close:21.950

Loading ...

Overview Company News Filings

3SBio Inc. Conducted Annual General Meeting

US Pharma Bets Big on China to Snap up Potential Blockbuster Drugs

HK Movers | HK's Biotech Shares Soar. Asymchem up 15%; Laekna up 13%; Ascletis, CanSinoBIO up 9%

Tiger Newspress

Stock Track | 3SBIO Soars 5.32% on $6 Billion Licensing Deal with Pfizer for Cancer Drug

3SBio to Grant Pfizer Exclusive License for Anti-Cancer Injection

MT Newswires Live

Hong Kong Stocks Rise as China Cuts Interest Rates; CATL Jumps 16% in Debut

MT Newswires Live

GLOBAL MARKETS-Asian stocks inch higher, Aussie dips as RBA cuts rates

China, HK stocks rise as rate cut boosts sentiment

Biotech Company 3SBio's Shares Surge After $6 Billion Licensing Deal With Pfizer

Pfizer Licenses 3SBio Cancer Drug for Record $1.2 Billion

Shares of 3SBio up 40% After Licensing Deal With Pfizer

THOMSON REUTERS

BUZZ-HK-listed 3SBio hits 7-year peak on Pfizer licensing deal

Pfizer in deal with China's 3SBio to license cancer drug candidate, take equity stake

Stock Track | 3SBIO Soars 14.90% on $6 Billion Licensing Deal with Pfizer for Cancer Drug

Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug

Sunshine Guojian Says Co and Affiliates Have Granted Pfizer an Exclusive License on Commercialization of Cancer Drug

THOMSON REUTERS

BRIEF-Sunshine Guojian Says Co And Affiliates Have Granted Pfizer An Exclusive License On Commercialization Of Cancer Drug

BRIEF-Pfizer Enters Into Exclusive Licensing Agreement With 3SBio

Pfizer Inc. Announces Exclusive Licensing Agreement with 3SBio for Development of Promising Cancer Drug SSGJ-707

3SBio Inc. Enters Exclusive License Agreement with Pfizer for PD-1/VEGF Bispecific Antibody

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/01530/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01530","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01530\",,,,,undefined,":{"symbol":"01530","market":"HK","secType":"STK","nameCN":"3SBIO","latestPrice":22.7,"timestamp":1751011733027,"preClose":21.95,"halted":0,"volume":31844000,"delay":0,"floatShares":2399000000,"shares":2399000000,"eps":0.9441541927986057,"marketStatus":"Market Closed","change":0.75,"latestTime":"06-27 16:08:53","open":22.25,"high":23.1,"low":21.45,"amount":705895958,"amplitude":0.075171,"askPrice":22.7,"askSize":290000,"bidPrice":22.65,"bidSize":14000,"shortable":3,"etf":0,"ttmEps":0.9304481443104745,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1751247000000},"marketStatusCode":7,"adr":0,"listingDate":1433952000000,"exchange":"SEHK","adjPreClose":21.95,"dividendRate":0.011307,"openAndCloseTimeList":[[1750987800000,1750996800000],[1751000400000,1751011200000]],"volumeRatio":0.9103468292741049,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01530\",,,,,undefined,":{"symbol":"01530","floatShares":2399000000,"roa":"6.82%","roe":"12.84%","lyrEps":0.944154,"volumeRatio":0.9103468292741049,"shares":2399000000,"dividePrice":0.257158,"high":23.1,"amplitude":0.075171,"preClose":21.95,"low":21.45,"week52Low":5.47,"pbRate":"3.22","psRate":"5.46","week52High":24.95,"institutionHeld":0,"latestPrice":22.7,"committee":-0.907895,"eps":0.9441541927986057,"divideRate":0.011329,"volume":31844000,"delay":0,"ttmEps":0.9304481443104745,"open":22.25,"prevYearClose":6.08,"prevWeekClose":20.8,"prevMonthClose":18.82,"prevQuarterClose":11.96,"fiveDayClose":20.8,"twentyDayClose":18.82,"sixtyDayClose":12.28},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01530\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2546219902","title":"3SBio Inc. Conducted Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2546219902","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546219902?lang=en_us&edition=fundamental","pubTime":"2025-06-25 18:27","pubTimestamp":1750847232,"startTime":"0","endTime":"0","summary":"3SBio Inc. held its annual general meeting on 25 June 2025. The proposal to receive and adopt the audited consolidated financial statements for the year ended 31 December 2024 and the reports of the directors and auditors was approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 3SBio Inc. published the original content used to generate this news brief on June 25, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nNDL4G5hyw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1583","01530","BK1593"],"gpt_icon":0},{"id":"2543675544","title":"US Pharma Bets Big on China to Snap up Potential Blockbuster Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2543675544","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543675544?lang=en_us&edition=fundamental","pubTime":"2025-06-17 13:17","pubTimestamp":1750137429,"startTime":"0","endTime":"0","summary":"FOCUS-US pharma bets big on China to snap up potential blockbuster drugsU.S. drugmakers turn to Chinese companies as they face patent expirations Licensing deals accelerate while traditional mergers decline Chinese biotechs are challenging Western peers, analysts sayBy Sriparna  Roy and Sneha  S K. June 16  - U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data, betting they can turn upfront payments of as little as $80 million into multibillion-dollar treatments.Through June, U.S. drugmakers have signed 14 deals potentially worth $18.3 billion to license drugs from China-based companies. That compares with just two such deals in the year-earlier period, according to data from GlobalData provided exclusively to Reuters.\"Chinese biotechs are moving up the value chain by the day. They are... challenging their Western peers,\" said Macquarie Capital analyst Tony Ren. The growth is happening even as the U.S. and China ","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nL4N3R61G6:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4534","LU1883839398.USD","LU0823416689.USD","LU2362541273.HKD","LU0321505439.SGD","IE00BLSP4239.USD","LU0225284248.USD","SG9999001176.USD","SG9999003800.SGD","BK1593","BK1583","REGN","LU0321505868.SGD","SGXZ57979304.SGD","LU0306807586.USD","LU0058720904.USD","LU0823434583.USD","LU2488822045.USD","BK4533","03692","LU2106854487.HKD","BK4592","LU1894683348.USD","LU2023250504.SGD","LU2362541513.USD","SG9999002224.SGD","LU1894683264.USD","NUVB","IE00B19Z3B42.SGD","LU0306806265.USD","IE00BBT3K403.USD","BK4581","LU0823434740.USD","BK4599","BK4550","IE0002270589.USD","LU0868494617.USD","SG9999013999.USD","IE000M9KFDE8.USD","SG9999001176.SGD","IE00B19Z3581.USD","LU2362540622.SGD","LU2089984988.USD","PFE","LU0114720955.EUR","01530","LU0053666078.USD","LU1023059063.AUD"],"gpt_icon":0},{"id":"1199180560","title":"HK Movers | HK's Biotech Shares Soar. Asymchem up 15%; Laekna up 13%; Ascletis, CanSinoBIO up 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1199180560","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199180560?lang=en_us&edition=fundamental","pubTime":"2025-05-21 11:19","pubTimestamp":1747797557,"startTime":"0","endTime":"0","summary":"Hong Kong’s biotech stocks rose on Tuesday.Asymchem rose 15%; Laekna rose 13%; Ascletis, CanSinoBIO rose 9%; Junshi Bio, Cstone Pharma rose 8%; 3SBio soared 7%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"305e35af160080a1ff409fd71b17ab9e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","02105","02137","02269","01672","02359","09995","03347","09606","06606","09688","01530","09966","02268","06821","03759","01877","06185"],"gpt_icon":1},{"id":"1106812790","title":"Stock Track | 3SBIO Soars 5.32% on $6 Billion Licensing Deal with Pfizer for Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1106812790","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106812790?lang=en_us&edition=fundamental","pubTime":"2025-05-21 09:36","pubTimestamp":1747791411,"startTime":"0","endTime":"0","summary":"3SBIO's stock  surged 5.32% in intraday trading on Wednesday, following the announcement of a major licensing agreement with pharmaceutical giant Pfizer for its promising cancer drug, SSGJ-707. This deal marks a significant milestone for the Chinese biotech company, propelling it into a leading position in the race for PD-1/VEGF antibody treatments.This deal positions 3SBIO as a strong contender in the competitive PD-1/VEGF antibody market. According to analysts, the agreement places 3SBIO and P","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"32bd8857c93003e7757eccf5ff11c4fd","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["01530"],"gpt_icon":1},{"id":"2536697918","title":"3SBio to Grant Pfizer Exclusive License for Anti-Cancer Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2536697918","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536697918?lang=en_us&edition=fundamental","pubTime":"2025-05-20 17:26","pubTimestamp":1747733215,"startTime":"0","endTime":"0","summary":"3SBio  and subsidiary Shenyang Sunshine Pharmaceutical will grant Pfizer an exclusive license to develop, manufacture, and commercialize its PD-1/VEGF injection for cancer worldwide excluding mainland China.Under the agreement, Pfizer will shoulder development and regulatory costs for future trials of the drug, the filing said.3SBio will be eligible to receive $1.25 billion in upfront payments and could receive up to $4.80 billion in development, regulatory approval and sales milestone payments.The SSGJ-707 drug is about to undergo phase 3 trials in China for programmed death-ligand 1-positive locally advanced or metastatic non-small cell lung cancer, according to a Tuesday filing with the Hong Kong bourse.It is also undergoing several phase 2 studies for the combination of the drug with chemotherapy for the first-line treatment of advanced non-small cell lung cancer, metastatic colorectal cancer, and advanced gynecological tumors.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"bd3435deb4a10905f161714b2e190399","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0002270589.USD","IE000M9KFDE8.USD","BK4585","LU0289739699.SGD","BK4533","LU1066051498.USD","IE00BLSP4452.SGD","SG9999003800.SGD","IE00B19Z3B42.SGD","LU0456855351.SGD","BK4534","SG9999001176.USD","BK4599","BK4007","SG9999002232.USD","IE00B19Z3581.USD","LU0225284248.USD","SG9999002224.SGD","BK1161","LU1894683348.USD","LU1023059063.AUD","SG9999011175.SGD","SG9999001176.SGD","BK1583","LU0122379950.USD","PFE","LU0985481810.HKD","BK4550","SG9999013999.USD","BK4581","LU1894683264.USD","IE00BBT3K403.USD","LU0225771236.USD","LU0321505439.SGD","LU1066053197.SGD","LU0868494617.USD","LU0306807586.USD","IE00BLSP4239.USD","BK4568","LU0170899867.USD","BK1593","LU0234572021.USD","LU0306806265.USD","BK4588","LU0058720904.USD","LU1057294990.SGD","01530","LU0321505868.SGD","BK4592","LU1883839398.USD"],"gpt_icon":1},{"id":"2536077691","title":"Hong Kong Stocks Rise as China Cuts Interest Rates; CATL Jumps 16% in Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2536077691","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536077691?lang=en_us&edition=fundamental","pubTime":"2025-05-20 16:58","pubTimestamp":1747731505,"startTime":"0","endTime":"0","summary":"Hong Kong stocks soared following a rate cut from China's central bank for the first time in seven months on Tuesday.The Hang Seng Index jumped 1.49%, or 348.76 points, to end at 23,681.48. The Hang Seng China Enterprises Index rose 1.52%, or by 128.53 points, to 8,589.08.Investor sentiment improved after The People's Bank of China slashed the one-year loan prime rate  to 3% from 3.1% previously and the five-year rate by 10 basis points to 3.5%.The move is in line with central bank Governor Pan Gongsheng's pledge to cut interest rates earlier in May to boost the economy.\"The decrease in the borrowing costs will be a major driver for stocks,\" the South China Morning Post said, citing Guotai Haitong Securities analyst Fang Yi.In corporate news, Contemporary Amperex Technology or CATL  made a strong trading debut in Hong Kong. The battery maker closed at HK$306.20 on Tuesday, over 16% higher than its IPO price of HK$263.Elsewhere, 3SBio  surged over 32% after it agreed to grant Pfizer an ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ce0ec89f75a15b0ca1bf7c6f9d3f2262","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1781817850.SGD","BK4599","LU1894683348.USD","LU0651947912.USD","LU2289578879.USD","513600","MHImain","LU0106252389.USD","LU0449515922.USD","IE00B19Z3581.USD","LU0509642566.USD","300750","LU0651946864.USD","LU1051768304.USD","LU2298064838.USD","03750","BK1161","HHImain","LU2348773727.SGD","LU0029875118.USD","LU0531971595.HKD","LU2476274308.USD","BK0224","BK4007","LU2148510915.USD","BK4585","LU0170899867.USD","LU0516423174.USD","IE00BD6J9T35.USD","LU0181495838.USD","LU1961090484.USD","LU0516423091.SGD","LU1023059063.AUD","LU0359202008.SGD","EVS.SI","LU1051769294.HKD","MCHmain","01530","LU2153592121.USD","LU0054450605.USD","LU2097828805.USD","LU0321505868.SGD","LU0225284248.USD","LU2476274720.SGD","HSI","LU1794554557.SGD","LU0607220059.USD","LU1880383366.USD","02833"],"gpt_icon":1},{"id":"2536661055","title":"GLOBAL MARKETS-Asian stocks inch higher, Aussie dips as RBA cuts rates","url":"https://stock-news.laohu8.com/highlight/detail?id=2536661055","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536661055?lang=en_us&edition=fundamental","pubTime":"2025-05-20 13:23","pubTimestamp":1747718624,"startTime":"0","endTime":"0","summary":"GLOBAL MARKETS-Asian stocks inch higher, Aussie dips as RBA cuts rates Investors shrug off Moody's US credit downgrade Dollar drifts as selloff in Treasuries easeRBA cuts rates as expected, Aussie down 0.5% CATL debuts in Hong Kong in world's biggest listing this yearUpdates to Asia afternoonBy Ankur Banerjee and Johann M Cherian. SINGAPORE, May 20  - Asian stocks rose on Tuesday while U.S. Treasury yields steadied, allowing a bit of a breathing room for the U.S. dollar as investors took stock of the debt load of the world's biggest economy and awaited trade deals.The Australian dollar AUD=D3 slipped 0.5% to $0.64255 after the Reserve Bank of Australia lowered interest rates as expected, citing a darker global outlook, though it also remained cautious on further easing.MOODY'S IMPACTU.S. Federal Reserve officials took on cautiously the ramifications of the Moody's downgrade as they continued to navigate an uncertain economic environment in the wake of erratic U.S. trade action.While no","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nL1N3RS02F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345769631.USD","LU0943347566.SGD","BK4516","SG9999015952.SGD","BK1593","TSYW.SI","IE00BK4W5L77.USD","LU2602419157.SGD","LU1548497426.USD","BK4574","LU0820562030.AUD","LU2290526834.HKD","LU0077335932.USD","LU1366192091.USD","BK4534","LU1066051498.USD","LU2471134952.CNY","LU0689472784.USD","LU1778281490.HKD","BK4543","LU2750360641.GBP","LU0345770308.USD","BK4612","LU1720051017.SGD","BK4588","LU1861215975.USD","LU2250418816.HKD","LU0820561818.USD","BK4550","LU0820561909.HKD","LU1429558221.USD","LU2756315318.SGD","01530","LU0348723411.USD","LU2756315664.SGD","LU0053666078.USD","LU2023250330.USD","BK4598","LU2357305700.SGD","LU1914381329.SGD","LU0323591593.USD","LU1435385759.SGD","LU0316494557.USD","LU0823411888.USD","LU1066053197.SGD","IE0034235303.USD","BK4581","LU0964807845.USD","BK4527"],"gpt_icon":1},{"id":"2536404669","title":"China, HK stocks rise as rate cut boosts sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=2536404669","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536404669?lang=en_us&edition=fundamental","pubTime":"2025-05-20 12:45","pubTimestamp":1747716312,"startTime":"0","endTime":"0","summary":"China, HK stocks rise as rate cut boosts sentiment By Summer Zhen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nL4N3RS043:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2265009873.SGD","BK1593","LU1267930730.SGD","BK1161","BK4588","LU0289961442.SGD","601162","BK1583","LU2210149790.SGD","LU0289739343.SGD","LU0175139822.USD","LU0708995401.HKD","LU1804176565.USD","BK4112","BK4585","MSCI","01530","LU0511384066.AUD","LU2210150020.SGD","BK0276","LU0672654240.SGD","LU2095319765.USD","LU0289960550.SGD","LU0109391861.USD","LU0320765059.SGD"],"gpt_icon":0},{"id":"2536066647","title":"Biotech Company 3SBio's Shares Surge After $6 Billion Licensing Deal With Pfizer","url":"https://stock-news.laohu8.com/highlight/detail?id=2536066647","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536066647?lang=en_us&edition=fundamental","pubTime":"2025-05-20 11:58","pubTimestamp":1747713480,"startTime":"0","endTime":"0","summary":"Chinese biotech company 3SBio's shares surged early Tuesday after its around US$6 billion licensing deal with Pfizer to develop, manufacture and commercialize a promising cancer drug.Shares were up 36% in Hong Kong to 19.78 Hong Kong dollars, equivalent to US$2.53, and on track to close at their highest level since 2018.Pfizer said late Monday that it had entered into an exclusive licensing agreement with Shenyang-based 3SBio to develop, manufacture and commercialize 3SBio's cancer drug SSGJ-707 outside of China.The drug is currently undergoing clinical trials in China for non-small cell lung cancer, metastatic colorectal cancer, and gynecological tumors.3SBio and its units will retain the development, manufacturing, commercialization, and other exploitation rights of the product within mainland China. Pfizer will also have the option of commercialization rights in China.Under the agreement, 3SBio will receive an upfront payment of US$1.25 billion and potential milestone payments up to","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"030ab8d842e83ef223b45b6bd16bca15","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4239.USD","LU0985481810.HKD","BK4550","LU1894683348.USD","BK4534","IE00BBT3K403.USD","LU0234572021.USD","LU0321505439.SGD","LU0868494617.USD","BK1161","BK4581","01530","LU0170899867.USD","LU0456855351.SGD","SG9999002224.SGD","BK1593","LU0225284248.USD","LU0225771236.USD","LU0306807586.USD","BK1583","LU0122379950.USD","SG9999001176.USD","LU1066051498.USD","SG9999011175.SGD","SGXZ57979304.SGD","LU1066053197.SGD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","LU1883839398.USD","PFE","SG9999013999.USD","LU0321505868.SGD","BK4588","BK4585","BK4592","BK4533","LU0289739699.SGD","SG9999001176.SGD","SG9999002232.USD","LU1023059063.AUD","IE0002270589.USD","LU0306806265.USD","SG9999003800.SGD","IE00B19Z3581.USD","LU0058720904.USD","LU1057294990.SGD","BK4599","IE000M9KFDE8.USD","LU1894683264.USD","BK4007"],"gpt_icon":1},{"id":"1146253372","title":"Pfizer Licenses 3SBio Cancer Drug for Record $1.2 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1146253372","media":"Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146253372?lang=en_us&edition=fundamental","pubTime":"2025-05-20 10:45","pubTimestamp":1747709158,"startTime":"0","endTime":"0","summary":"$Pfizer(PFE)$ will pay $1.25 billion upfront to license an experimental cancer drug out of China, in a deal that underscores multinational drugmakers’ growing enthusiasm for Chinese biotech innovation","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"030ab8d842e83ef223b45b6bd16bca15","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bloomberg.com/news/articles/2025-05-20/pfizer-licenses-3sbio-cancer-drug-for-record-1-2-billion","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Pfizer Licenses 3SBio Cancer Drug for Record $1.2 Billion","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1584095487587","symbols":["PFE","01530"],"gpt_icon":0},{"id":"2536501206","title":"Shares of 3SBio  up 40% After Licensing Deal With Pfizer","url":"https://stock-news.laohu8.com/highlight/detail?id=2536501206","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536501206?lang=en_us&edition=fundamental","pubTime":"2025-05-20 10:14","pubTimestamp":1747707282,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nL4N3RS05N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BLSP4239.USD","SG9999001176.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","PFE","BK1593","BK4592","01530","LU1066051498.USD","LU1894683348.USD","SG9999011175.SGD","SG9999003800.SGD","SG9999013999.USD","LU1894683264.USD","BK4533","LU0122379950.USD","BK1583","LU0234572021.USD","LU0058720904.USD","LU0289739699.SGD","LU0868494617.USD","SG9999001176.USD","IE00B19Z3581.USD","BK4568","BK4585","LU1883839398.USD","LU0170899867.USD","LU0306806265.USD","BK4007","LU0321505868.SGD","BK1161","BK4534","SG9999002224.SGD","LU0321505439.SGD","BK4550","LU0225284248.USD","LU0306807586.USD","LU1057294990.SGD","IE0002270589.USD","BK4588","IE00B19Z3B42.SGD","IE000M9KFDE8.USD","LU0456855351.SGD","LU1066053197.SGD","BK4599","LU1023059063.AUD","BK4581","IE00BLSP4452.SGD","LU0985481810.HKD","SG9999002232.USD"],"gpt_icon":0},{"id":"2536650641","title":"BUZZ-HK-listed 3SBio hits 7-year peak on Pfizer licensing deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2536650641","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536650641?lang=en_us&edition=fundamental","pubTime":"2025-05-20 10:13","pubTimestamp":1747707238,"startTime":"0","endTime":"0","summary":"BUZZ-HK-listed 3SBio hits 7-year peak on Pfizer licensing deal** Shares of Chinese biopharmaceutical products developer 3SBio Inc 1530.HK jump as much as 51.7% to HK$22, highest since June 2018** Set for biggest one-day pct rise since listing in 2015; top pct gainer on Hang Seng Biotech Index .HSHKBIO and healthcare index .HSCIH, which are up 2.7% and 2.6%** Pfizer FE.N has signed a $6 billion licensing agreement with 3SBio Inc for development, manufacturing and commercialization of a drug that could be used to treat certain types of cancer and tumors** 3SBio and its subsidiaries will grant Pfizer a global license, excluding China, for the drug SSGJ-707, with an option for Pfizer to obtain commercialization rights in China** Pfizer to also make a $100 million investment in 3SBio after transaction close, expected in Q3** 3SBio's unit Sunshine Guojian Pharmaceutical 688336.SS jumps 20% to 39.37 yuan, highest since August 2020  ** Hang Seng Index .HSI rises 1%** YTD, 3SBio stock up 217.8%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"030ab8d842e83ef223b45b6bd16bca15","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nL1N3RS02C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU1894683264.USD","SG9999011175.SGD","SG9999002232.USD","LU0122379950.USD","BK4588","IE00BLSP4452.SGD","LU1883839398.USD","LU0289739699.SGD","LU0225284248.USD","BK4592","LU0985481810.HKD","SG9999001176.SGD","SG9999013999.USD","LU0170899867.USD","SGXZ57979304.SGD","LU0306807586.USD","BK4533","SG9999003800.SGD","LU0456855351.SGD","IE000M9KFDE8.USD","BK1583","IE00BLSP4239.USD","SG9999002224.SGD","LU1057294990.SGD","IE00BBT3K403.USD","01530","LU1066051498.USD","688336","BK0239","BK1593","LU1066053197.SGD","LU0321505439.SGD","IE0002270589.USD","BK4599","LU0321505868.SGD","LU1023059063.AUD","BK1161","BK4568","BK4550","LU0058720904.USD","IE00B19Z3B42.SGD","LU0225771236.USD","LU0234572021.USD","BK4007","IE00B19Z3581.USD","BK4585","SG9999001176.USD","BK4534"],"gpt_icon":1},{"id":"2536652157","title":"Pfizer in deal with China's 3SBio to license cancer drug candidate, take equity stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2536652157","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536652157?lang=en_us&edition=fundamental","pubTime":"2025-05-20 09:36","pubTimestamp":1747704999,"startTime":"0","endTime":"0","summary":"UPDATE 3-Pfizer in deal with China's 3SBio to license cancer drug candidate, take equity stakeAdds industry context and details on 3SBio business in paragraphs 4-5, 10. 3SBio has facilities in China and Italy and its products were sold in 20 countries in 2024,. Core products include a treatment for thrombocytopenia, TPIAO, and small molecule drug Mandi.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nL4N3RS019:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999013999.USD","PFE","BK4592","BK4534","BK4550","LU1894683264.USD","LU0456855351.SGD","BK4007","SGXZ57979304.SGD","LU1023059063.AUD","IE00BLSP4239.USD","BK4581","LU0225284248.USD","BK4585","BK1593","SG9999003800.SGD","IE00BLSP4452.SGD","LU0234572021.USD","01530","IE00B19Z3581.USD","LU0122379950.USD","LU0289739699.SGD","BK4533","SG9999001176.SGD","LU0306807586.USD","LU1057294990.SGD","SG9999001176.USD","LU1883839398.USD","IE00B19Z3B42.SGD","LU0321505868.SGD","LU0170899867.USD","LU0225771236.USD","BK1583","LU0058720904.USD","IE00BBT3K403.USD","SG9999002224.SGD","BK4599","BK4588","LU0985481810.HKD","LU0321505439.SGD","IE0002270589.USD","LU0306806265.USD","LU0868494617.USD","LU1066051498.USD","BK1161","LU1066053197.SGD","SG9999011175.SGD","BK4568","IE000M9KFDE8.USD","LU1894683348.USD"],"gpt_icon":1},{"id":"1158843816","title":"Stock Track | 3SBIO Soars 14.90% on $6 Billion Licensing Deal with Pfizer for Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1158843816","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158843816?lang=en_us&edition=fundamental","pubTime":"2025-05-20 09:31","pubTimestamp":1747704677,"startTime":"0","endTime":"0","summary":"3SBIO  shares skyrocketed 14.90% in pre-market trading on Tuesday, following the announcement of a major licensing agreement with pharmaceutical giant Pfizer for its promising cancer drug SSGJ-707. The deal, potentially worth up to $6 billion, marks a significant milestone for the Chinese biopharmaceutical company and has sparked investor enthusiasm.This landmark deal not only provides 3SBIO with substantial immediate cash flow but also validates the potential of its drug pipeline. Investors are","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"030ab8d842e83ef223b45b6bd16bca15","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Stock Track | 3SBIO Soars 14.90% on $6 Billion Licensing Deal with Pfizer for Cancer Drug","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["01530"],"gpt_icon":0},{"id":"2536365186","title":"Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2536365186","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536365186?lang=en_us&edition=fundamental","pubTime":"2025-05-20 08:31","pubTimestamp":1747701085,"startTime":"0","endTime":"0","summary":"Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drugMay 19  - Pfizer PFE.N has signed a licensing agreement worth up to $6 billion with Chinese pharmaceutical products developer 3SBio Inc 1530.HK for the development, manufacturing and commercialization of a drug undergoing trials for treatment of certain types of cancer and tumours, the U.S. drugmaker said on Monday.   ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nL4N3RS00X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4239.USD","LU0985481810.HKD","BK4550","LU1894683348.USD","BK4534","BK4568","IE00BBT3K403.USD","LU0234572021.USD","LU0321505439.SGD","LU0868494617.USD","BK4581","SG9999002224.SGD","01530","LU0170899867.USD","LU0456855351.SGD","BK1593","LU0225284248.USD","LU0225771236.USD","LU0306807586.USD","BK1583","LU0122379950.USD","SG9999001176.USD","LU1066051498.USD","SG9999011175.SGD","SGXZ57979304.SGD","LU1066053197.SGD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","LU1883839398.USD","PFE","SG9999013999.USD","LU0321505868.SGD","BK4588","BK4585","BK4592","BK4533","LU0289739699.SGD","SG9999001176.SGD","SG9999002232.USD","LU1023059063.AUD","IE0002270589.USD","LU0306806265.USD","SG9999003800.SGD","IE00B19Z3581.USD","LU0058720904.USD","LU1057294990.SGD","BK4599","IE000M9KFDE8.USD","LU1894683264.USD","BK4007"],"gpt_icon":1},{"id":"2536659163","title":"Sunshine Guojian  Says Co and Affiliates Have Granted Pfizer an Exclusive License on Commercialization of Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2536659163","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536659163?lang=en_us&edition=fundamental","pubTime":"2025-05-20 08:24","pubTimestamp":1747700689,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nL4N3RS00T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4585","LU0225771236.USD","BK4534","LU1883839398.USD","LU0456855351.SGD","LU0321505439.SGD","IE00BLSP4239.USD","LU0985481810.HKD","BK1161","LU0225284248.USD","LU0234572021.USD","SG9999001176.USD","SG9999003800.SGD","LU0289739699.SGD","BK1593","BK1583","LU0321505868.SGD","SG9999002232.USD","SGXZ57979304.SGD","LU0306807586.USD","IE00BLSP4452.SGD","LU0058720904.USD","LU1066051498.USD","BK4533","BK4592","LU1894683348.USD","BK4588","SG9999002224.SGD","LU1894683264.USD","IE00B19Z3B42.SGD","LU0306806265.USD","IE00BBT3K403.USD","BK4581","LU1066053197.SGD","BK4599","BK4550","BK4007","IE0002270589.USD","688336","BK0239","IE000M9KFDE8.USD","SG9999001176.SGD","IE00B19Z3581.USD","SG9999013999.USD","PFE","LU0122379950.USD","01530","LU0170899867.USD","LU1023059063.AUD"],"gpt_icon":0},{"id":"2536594016","title":"BRIEF-Sunshine Guojian Says Co And Affiliates Have Granted Pfizer An Exclusive License On Commercialization Of Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2536594016","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536594016?lang=en_us&edition=fundamental","pubTime":"2025-05-20 08:24","pubTimestamp":1747700689,"startTime":"0","endTime":"0","summary":"BRIEF-Sunshine Guojian Says Co And Affiliates Have Granted Pfizer An Exclusive License On Commercialization Of Cancer DrugMay 20  - Sunshine Guojian Pharmaceutical Shanghai Co Ltd 688336.SS:SAYS CO AND AFFILIATES HAVE GRANTED PFIZER AN EXCLUSIVE LICENSE ON COMMERCIALIZATION OF CANCER DRUGSource textFurther company coverage: 688336.SS  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nL4N3RS00T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0985481810.HKD","LU1066051498.USD","LU0058720904.USD","LU0170899867.USD","IE00BLSP4452.SGD","LU1066053197.SGD","LU1894683264.USD","PFE","BK4533","BK1593","BK4568","01530","LU0225284248.USD","IE00BBT3K403.USD","BK4581","BK4550","SG9999001176.SGD","LU0289739699.SGD","BK4007","LU0234572021.USD","BK4585","BK1583","IE0002270589.USD","IE00BLSP4239.USD","SG9999002232.USD","SGXZ57979304.SGD","SG9999002224.SGD","LU1883839398.USD","BK0239","LU1023059063.AUD","BK4588","LU0306807586.USD","BK4599","IE000M9KFDE8.USD","SG9999013999.USD","LU0306806265.USD","SG9999003800.SGD","LU0225771236.USD","BK4592","IE00B19Z3B42.SGD","LU0321505439.SGD","BK1161","LU1894683348.USD","688336","LU0456855351.SGD","SG9999001176.USD","LU0321505868.SGD","BK4534","LU0122379950.USD","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2536365670","title":"BRIEF-Pfizer Enters Into Exclusive Licensing Agreement With 3SBio","url":"https://stock-news.laohu8.com/highlight/detail?id=2536365670","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536365670?lang=en_us&edition=fundamental","pubTime":"2025-05-20 08:03","pubTimestamp":1747699394,"startTime":"0","endTime":"0","summary":"BRIEF-Pfizer Enters Into Exclusive Licensing Agreement With 3SBioMay 19 (Reuters) - Pfizer Inc PFE.N:PFIZER ENTERS INTO EXCLUSIVE LICENSING AGREEMENT WITH 3SBIOPFIZER INC - 3SBIO TO RECEIVE $1.25 BILL","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"030ab8d842e83ef223b45b6bd16bca15","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nTUA9NWTS2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU0321505868.SGD","BK1583","LU0321505439.SGD","SGXZ57979304.SGD","LU1023059063.AUD","BK4585","IE0002270589.USD","IE00B19Z3B42.SGD","BK4568","IE00BLSP4239.USD","LU0456855351.SGD","BK1161","BK4533","BK4588","LU0868494617.USD","BK4599","LU1894683348.USD","LU0234572021.USD","BK4007","PFE","01530","SG9999002224.SGD","BK4534","SG9999011175.SGD","LU0170899867.USD","IE00BBT3K403.USD","LU1894683264.USD","IE00B19Z3581.USD","LU0225284248.USD","LU0306807586.USD","BK4550","SG9999002232.USD","SG9999003800.SGD","SG9999001176.USD","BK4581","IE000M9KFDE8.USD","IE00BLSP4452.SGD","LU1883839398.USD","SG9999013999.USD","LU0306806265.USD","LU1066051498.USD","LU0985481810.HKD","BK1593","LU1066053197.SGD","LU0122379950.USD","LU0225771236.USD","LU0289739699.SGD","LU1057294990.SGD","SG9999001176.SGD"],"gpt_icon":1},{"id":"2536656426","title":"Pfizer Inc. Announces Exclusive Licensing Agreement with 3SBio for Development of Promising Cancer Drug SSGJ-707","url":"https://stock-news.laohu8.com/highlight/detail?id=2536656426","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536656426?lang=en_us&edition=fundamental","pubTime":"2025-05-20 08:00","pubTimestamp":1747699219,"startTime":"0","endTime":"0","summary":"Pfizer Inc. has announced an exclusive global licensing agreement with 3SBio, Inc., a prominent Chinese biopharmaceutical company, for the development, manufacturing, and commercialization of SSGJ-707. This bispecific antibody targets PD-1 and VEGF and is currently involved in clinical trials in China for various cancers, including non-small cell lung cancer, metastatic colorectal cancer, and gynecological tumors. Under the agreement, Pfizer will gain an exclusive global license, excluding China, and will make a $100 million equity investment in 3SBio upon closing, subject to customary conditions and approvals. Additionally, 3SBio will receive an upfront payment of $1.25 billion and may receive up to $4.8 billion in milestone payments. Tiered double-digit royalties on sales of SSGJ-707, if approved, are also part of the agreement. Pfizer plans to produce the drug substance in Sanford, North Carolina, and the drug product in McPherson, Kansas.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"bd3435deb4a10905f161714b2e190399","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nNDL666Bj5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","BK4585","BK4581","LU0306806265.USD","SG9999013999.USD","BK1161","SG9999002224.SGD","LU0306807586.USD","SG9999002232.USD","LU0058720904.USD","LU0170899867.USD","LU0985481810.HKD","01530","LU0122379950.USD","LU1066053197.SGD","LU1894683264.USD","BK4592","LU0225284248.USD","BK4533","LU0225771236.USD","BK4588","LU1066051498.USD","LU1894683348.USD","BK4534","LU0868494617.USD","SG9999003800.SGD","IE000M9KFDE8.USD","LU0321505868.SGD","BK4550","BK4568","LU1057294990.SGD","LU0321505439.SGD","BK1583","SG9999001176.SGD","LU0289739699.SGD","BK4599","SG9999011175.SGD","SG9999001176.USD","PFE","IE00B19Z3B42.SGD","LU1883839398.USD","IE00B19Z3581.USD","SGXZ57979304.SGD","LU0456855351.SGD","IE00BBT3K403.USD","LU1023059063.AUD","IE00BLSP4452.SGD","IE00BLSP4239.USD","IE0002270589.USD","BK4007"],"gpt_icon":1},{"id":"2536655685","title":"3SBio Inc. Enters Exclusive License Agreement with Pfizer for PD-1/VEGF Bispecific Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=2536655685","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536655685?lang=en_us&edition=fundamental","pubTime":"2025-05-20 07:04","pubTimestamp":1747695868,"startTime":"0","endTime":"0","summary":"3SBio Inc. has announced the signing of an exclusive licensing agreement with Pfizer Inc. for the development of a PD-1/VEGF bispecific antibody known as SSGJ-707. This agreement is a strategic move aimed at bringing the innovative treatment to patients worldwide. Additionally, 3SBio revealed that there is a possibility of Pfizer subscribing to a number of new shares of the company, although no binding agreement has been reached on this potential subscription. The company advises shareholders and potential investors to exercise caution when dealing with its shares. The agreement also includes an option for Pfizer to commercialize the licensed product in mainland China, pending regulatory approvals. Morgan Stanley Asia Limited and Han Kun Law Offices are advising 3SBio on this transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"bd3435deb4a10905f161714b2e190399","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nNDL9dk68T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU1066051498.USD","LU0456855351.SGD","BK4588","SG9999002224.SGD","LU0225283273.USD","IE000M9KFDE8.USD","IE0002270589.USD","LU0225284248.USD","SG9999001176.USD","BK4127","SG9999001176.SGD","LU2089284900.SGD","LU1162221912.USD","01530","SG9999011175.SGD","BK4581","BK4568","LU0106831901.USD","IE00BKVL7J92.USD","BK1593","LU0795875086.SGD","BK4533","LU0795875169.SGD","LU0321505868.SGD","LU1720051108.HKD","LU0320765646.SGD","LU1057294990.SGD","LU1732799900.SGD","LU1894683348.USD","LU2133065610.SGD","BK4550","PFE","SG9999013999.USD","LU0106261372.USD","LU0985481810.HKD","LU0058720904.USD","LU0306806265.USD","BK4592","LU0912757837.SGD","BK4585","LU2023251221.USD","IE00BZ1G4Q59.USD","BK4504","LU1363072403.SGD","LU2028103732.USD","LU2347655156.SGD","LU1732800096.USD","LU0122379950.USD","LU0314104364.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":41,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01530\",params:#limit:5,,,undefined,":[{"date":"2025-07-21","symbol":"01530","amount":0.25,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-07-22","defaultRemindTime":1753061400000,"name":"三生制药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-15","payableDate":"2025-07-22","currency":"HKD","dateTimestamp":1753027200000,"payDate":"2025-08-15"},{"date":"2025-03-25","symbol":"01530","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742866200000,"name":null,"time":"Post Market","dateTimestamp":1742832000000,"actualEps":null},{"date":"2024-08-22","symbol":"01530","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724290200000,"name":null,"time":"Post Market","dateTimestamp":1724256000000,"actualEps":null},{"date":"2024-07-22","symbol":"01530","amount":0.25,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2024-07-23","defaultRemindTime":1721611800000,"name":"三生制药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-08-05","payableDate":"2024-07-23","currency":"HKD","dateTimestamp":1721577600000,"payDate":"2024-08-05"},{"date":"2024-03-20","symbol":"01530","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1710898200000,"name":null,"time":"","dateTimestamp":1710864000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01530\",market:\"HK\",,,undefined,":[{"executeDate":"2018-06-29","recordDate":"2018-07-03","paymentDate":"2018-07-30","value":0.0685,"currency":"HKD"},{"executeDate":"2022-06-27","recordDate":null,"paymentDate":"2022-07-11","value":0.2,"currency":"HKD"},{"executeDate":"2023-06-27","recordDate":"2023-06-28","paymentDate":"2023-07-11","value":0.1,"currency":"HKD"},{"executeDate":"2024-07-22","recordDate":"2024-07-23","paymentDate":"2024-08-05","value":0.25,"currency":"HKD"},{"executeDate":"2025-07-21","recordDate":"2025-07-22","paymentDate":"2025-08-15","value":0.25,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01530\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.5,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":10,"updateTime":1750348800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01530\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01530","date":"2025-06-27","current":23.392241,"percent":0.965126,"low":5.649976,"twenty":7.728699,"median":9.273129,"eighty":14.074787,"high":32.616228,"avg":11.366286,"sd":4.882537,"marketCap":53550008784},"quantilePoints":[{"date":"2020-07-03","current":25.57706,"twenty":18.977388,"median":21.380685,"eighty":23.420556,"marketCap":27314379780},{"date":"2020-07-10","current":30.04465,"twenty":19.199234,"median":21.624268,"eighty":23.509061,"marketCap":32391402044},{"date":"2020-07-17","current":28.351386,"twenty":19.230471,"median":21.784542,"eighty":23.606481,"marketCap":30614444251},{"date":"2020-07-24","current":23.553786,"twenty":19.27601,"median":22.03771,"eighty":23.717778,"marketCap":25334341097},{"date":"2020-07-31","current":22.146262,"twenty":19.32458,"median":22.148181,"eighty":23.68653,"marketCap":23960240990},{"date":"2020-08-07","current":21.582253,"twenty":19.371354,"median":22.156771,"eighty":23.668161,"marketCap":23375224490},{"date":"2020-08-14","current":21.996768,"twenty":19.461546,"median":22.116274,"eighty":23.608902,"marketCap":23883934490},{"date":"2020-08-21","current":15.787091,"twenty":19.230471,"median":21.995933,"eighty":23.551365,"marketCap":23960240990},{"date":"2020-08-28","current":15.880993,"twenty":18.638495,"median":21.901546,"eighty":23.537633,"marketCap":24290902490},{"date":"2020-09-04","current":14.882704,"twenty":18.106528,"median":21.649951,"eighty":23.52107,"marketCap":22841078991},{"date":"2020-09-11","current":14.022448,"twenty":17.780133,"median":21.582253,"eighty":23.517767,"marketCap":21543868491},{"date":"2020-09-18","current":14.740426,"twenty":17.521864,"median":21.36606,"eighty":23.509061,"marketCap":22866514491},{"date":"2020-09-25","current":13.585833,"twenty":16.548516,"median":21.256355,"eighty":23.498133,"marketCap":20907980991},{"date":"2020-09-30","current":14.344092,"twenty":15.930965,"median":21.216374,"eighty":23.483967,"marketCap":22180200711},{"date":"2020-10-09","current":13.848614,"twenty":15.735354,"median":21.159797,"eighty":23.461821,"marketCap":21722352531},{"date":"2020-10-16","current":13.189162,"twenty":15.378469,"median":21.131217,"eighty":23.430517,"marketCap":20679476121},{"date":"2020-10-23","current":12.391258,"twenty":15.269647,"median":21.000337,"eighty":23.410882,"marketCap":19458547642},{"date":"2020-10-30","current":11.676755,"twenty":14.998865,"median":20.979347,"eighty":23.363794,"marketCap":18339363202},{"date":"2020-11-06","current":11.877973,"twenty":14.690017,"median":20.896428,"eighty":23.30781,"marketCap":18873519412},{"date":"2020-11-13","current":12.011956,"twenty":14.427697,"median":20.722924,"eighty":23.266795,"marketCap":19102443502},{"date":"2020-11-20","current":12.048361,"twenty":14.333539,"median":20.418285,"eighty":23.20982,"marketCap":19280495572},{"date":"2020-11-27","current":11.869467,"twenty":14.243444,"median":20.277362,"eighty":23.180118,"marketCap":18949827442},{"date":"2020-12-04","current":11.863764,"twenty":14.007178,"median":20.215131,"eighty":23.163809,"marketCap":19077007492},{"date":"2020-12-11","current":10.813991,"twenty":13.879087,"median":19.748525,"eighty":23.152109,"marketCap":17347358813},{"date":"2020-12-18","current":11.746326,"twenty":13.824927,"median":19.678609,"eighty":23.150166,"marketCap":18873519412},{"date":"2020-12-24","current":11.512821,"twenty":13.346896,"median":19.553409,"eighty":23.133368,"marketCap":18517415272},{"date":"2020-12-31","current":11.176142,"twenty":12.885666,"median":19.399862,"eighty":23.103596,"marketCap":17983259062},{"date":"2021-01-08","current":10.951057,"twenty":10.975298,"median":11.176142,"eighty":11.338002,"marketCap":17779770983},{"date":"2021-01-15","current":10.903863,"twenty":10.829347,"median":10.989897,"eighty":11.324423,"marketCap":17678026943},{"date":"2021-01-22","current":11.96006,"twenty":10.893666,"median":11.138396,"eighty":11.457272,"marketCap":19382239612},{"date":"2021-01-29","current":11.254884,"twenty":10.919998,"median":11.285586,"eighty":11.564584,"marketCap":18390235222},{"date":"2021-02-05","current":12.685187,"twenty":10.942936,"median":11.340068,"eighty":11.943922,"marketCap":20603168091},{"date":"2021-02-11","current":12.46373,"twenty":10.965968,"median":11.447067,"eighty":12.289931,"marketCap":20272499962},{"date":"2021-02-19","current":13.708813,"twenty":10.98896,"median":11.531282,"eighty":12.474049,"marketCap":22307380761},{"date":"2021-02-26","current":12.09409,"twenty":11.020846,"median":11.810324,"eighty":12.771417,"marketCap":19636599712},{"date":"2021-03-05","current":11.747557,"twenty":11.145945,"median":11.933164,"eighty":12.661366,"marketCap":19026135472},{"date":"2021-03-12","current":11.673762,"twenty":11.145945,"median":11.764748,"eighty":12.557433,"marketCap":18873519412},{"date":"2021-03-19","current":11.567481,"twenty":11.19189,"median":11.778346,"eighty":12.517269,"marketCap":18695467342},{"date":"2021-03-26","current":10.891613,"twenty":11.117482,"median":11.684905,"eighty":12.493731,"marketCap":17525410883},{"date":"2021-04-01","current":17.985497,"twenty":11.112253,"median":11.721802,"eighty":12.56608,"marketCap":17805206993},{"date":"2021-04-09","current":18.432989,"twenty":11.127939,"median":11.778346,"eighty":12.807919,"marketCap":18288491182},{"date":"2021-04-16","current":17.862157,"twenty":11.161044,"median":11.865003,"eighty":13.241029,"marketCap":17789234973},{"date":"2021-04-23","current":19.042838,"twenty":11.223387,"median":11.933164,"eighty":15.47132,"marketCap":19012563452},{"date":"2021-04-30","current":18.710444,"twenty":11.277395,"median":12.054991,"eighty":17.868836,"marketCap":18757703352},{"date":"2021-05-07","current":17.554408,"twenty":11.306734,"median":12.256451,"eighty":17.915192,"marketCap":17712776943},{"date":"2021-05-14","current":19.436163,"twenty":11.316587,"median":12.453788,"eighty":17.999619,"marketCap":19598741682},{"date":"2021-05-21","current":19.607681,"twenty":11.324722,"median":12.482713,"eighty":18.355798,"marketCap":19777143752},{"date":"2021-05-28","current":22.268767,"twenty":11.338002,"median":12.522845,"eighty":18.529646,"marketCap":22682548891},{"date":"2021-06-04","current":23.506716,"twenty":11.345592,"median":12.739081,"eighty":18.831667,"marketCap":23829989690},{"date":"2021-06-11","current":26.450129,"twenty":11.384641,"median":12.957551,"eighty":19.026489,"marketCap":26811924229},{"date":"2021-06-18","current":27.883097,"twenty":11.434041,"median":13.165771,"eighty":19.07752,"marketCap":28035281989},{"date":"2021-06-25","current":25.719333,"twenty":11.457054,"median":13.641205,"eighty":19.573377,"marketCap":25843432669},{"date":"2021-07-02","current":23.991316,"twenty":11.497003,"median":15.724677,"eighty":20.625755,"marketCap":24064953030},{"date":"2021-07-09","current":21.038896,"twenty":11.531282,"median":17.620941,"eighty":22.268767,"marketCap":21082326436},{"date":"2021-07-16","current":21.649903,"twenty":11.562167,"median":17.801719,"eighty":22.22185,"marketCap":21694147276},{"date":"2021-07-23","current":19.947305,"twenty":11.567481,"median":17.862157,"eighty":22.084791,"marketCap":19986147432},{"date":"2021-07-30","current":16.406492,"twenty":11.59769,"median":17.801719,"eighty":21.788189,"marketCap":16493670138},{"date":"2021-08-06","current":16.802074,"twenty":11.614538,"median":17.743633,"eighty":21.649903,"marketCap":16850565628},{"date":"2021-08-13","current":18.886134,"twenty":11.673762,"median":17.779702,"eighty":21.183606,"marketCap":18966446032},{"date":"2021-08-20","current":17.768797,"twenty":11.696048,"median":17.819034,"eighty":21.038896,"marketCap":17793789423},{"date":"2021-08-27","current":16.692119,"twenty":11.747557,"median":17.801719,"eighty":21.033586,"marketCap":20735050481},{"date":"2021-09-03","current":17.466007,"twenty":11.778346,"median":17.768797,"eighty":20.834949,"marketCap":21705193951},{"date":"2021-09-10","current":17.537221,"twenty":11.781939,"median":17.749396,"eighty":20.79403,"marketCap":21849743511},{"date":"2021-09-17","current":16.873614,"twenty":11.829513,"median":17.593173,"eighty":20.713648,"marketCap":20960774196},{"date":"2021-09-24","current":15.891613,"twenty":11.886297,"median":17.584775,"eighty":20.643334,"marketCap":19750043557},{"date":"2021-09-30","current":15.474503,"twenty":11.914957,"median":17.537221,"eighty":20.597572,"marketCap":19296019567},{"date":"2021-10-08","current":14.868338,"twenty":11.929738,"median":17.471827,"eighty":20.523384,"marketCap":18539312917},{"date":"2021-10-15","current":14.534703,"twenty":11.943922,"median":17.393521,"eighty":20.409691,"marketCap":18135736037},{"date":"2021-10-22","current":15.254007,"twenty":11.992262,"median":17.164588,"eighty":20.155654,"marketCap":19169901792},{"date":"2021-10-29","current":14.32602,"twenty":12.052106,"median":16.901646,"eighty":19.822619,"marketCap":17959171152},{"date":"2021-11-05","current":13.860523,"twenty":12.079287,"median":16.802074,"eighty":19.624426,"marketCap":17404252943},{"date":"2021-11-12","current":14.383763,"twenty":12.159034,"median":16.779243,"eighty":19.588676,"marketCap":18135736037},{"date":"2021-11-19","current":13.622836,"twenty":12.278771,"median":16.568761,"eighty":19.510566,"marketCap":17152017393},{"date":"2021-11-26","current":13.298043,"twenty":12.364889,"median":16.431408,"eighty":19.425837,"marketCap":16748440513},{"date":"2021-12-03","current":13.533375,"twenty":12.451799,"median":16.380162,"eighty":19.304184,"marketCap":17076346728},{"date":"2021-12-10","current":13.530262,"twenty":12.46889,"median":15.9828,"eighty":19.12088,"marketCap":17101570283},{"date":"2021-12-17","current":13.559592,"twenty":12.481497,"median":15.474503,"eighty":19.070251,"marketCap":17126793838},{"date":"2021-12-24","current":13.187537,"twenty":12.491264,"median":15.316496,"eighty":19.046201,"marketCap":16672769848},{"date":"2021-12-31","current":12.939931,"twenty":12.50054,"median":15.276462,"eighty":19.041674,"marketCap":16395310743},{"date":"2022-01-07","current":12.629546,"twenty":12.669271,"median":12.939931,"eighty":13.294377,"marketCap":15941286753},{"date":"2022-01-14","current":13.31994,"twenty":12.739596,"median":13.158397,"eighty":13.389669,"marketCap":16849334733},{"date":"2022-01-21","current":13.110466,"twenty":12.821107,"median":13.146404,"eighty":13.374152,"marketCap":16622322738},{"date":"2022-01-28","current":11.290609,"twenty":12.592795,"median":13.025199,"eighty":13.33992,"marketCap":14278449114},{"date":"2022-02-04","current":11.73951,"twenty":11.988397,"median":12.937634,"eighty":13.31994,"marketCap":14838866059},{"date":"2022-02-11","current":12.600787,"twenty":11.988397,"median":12.895764,"eighty":13.209556,"marketCap":15959699948},{"date":"2022-02-18","current":12.386052,"twenty":12.386052,"median":12.812393,"eighty":13.193339,"marketCap":15764772315},{"date":"2022-02-25","current":11.935463,"twenty":11.988397,"median":12.695755,"eighty":13.170389,"marketCap":15228721325},{"date":"2022-03-04","current":11.339121,"twenty":11.902053,"median":12.615167,"eighty":13.146404,"marketCap":14473376747},{"date":"2022-03-11","current":10.811811,"twenty":11.786733,"median":12.537668,"eighty":13.131086,"marketCap":13779476577},{"date":"2022-03-18","current":11.43147,"twenty":11.43147,"median":12.408169,"eighty":13.110466,"marketCap":14511130201},{"date":"2022-03-25","current":11.488626,"twenty":11.433439,"median":12.316063,"eighty":13.033248,"marketCap":14584295563},{"date":"2022-04-01","current":7.736942,"twenty":11.290609,"median":12.024306,"eighty":12.939931,"marketCap":15730552907},{"date":"2022-04-08","current":7.901451,"twenty":10.775992,"median":11.96193,"eighty":12.936256,"marketCap":16071991265},{"date":"2022-04-14","current":7.650324,"twenty":9.945202,"median":11.917347,"eighty":12.911593,"marketCap":15535445274},{"date":"2022-04-22","current":6.804709,"twenty":7.91723,"median":11.900612,"eighty":12.888104,"marketCap":13559980490},{"date":"2022-04-29","current":6.903581,"twenty":7.657518,"median":11.816815,"eighty":12.868353,"marketCap":13535592036},{"date":"2022-05-06","current":6.547485,"twenty":7.585282,"median":11.73951,"eighty":12.838535,"marketCap":12730773050},{"date":"2022-05-13","current":7.024374,"twenty":7.5042,"median":11.586418,"eighty":12.768824,"marketCap":13413649766},{"date":"2022-05-20","current":7.191673,"twenty":7.191673,"median":11.454736,"eighty":12.716391,"marketCap":13925807302},{"date":"2022-05-27","current":7.00883,"twenty":7.024374,"median":11.35879,"eighty":12.695755,"marketCap":13559980490},{"date":"2022-06-02","current":7.284877,"twenty":7.084601,"median":11.290609,"eighty":12.646528,"marketCap":14169691843},{"date":"2022-06-10","current":8.17995,"twenty":7.134723,"median":10.844875,"eighty":12.630481,"marketCap":15803718269},{"date":"2022-06-17","current":8.201566,"twenty":7.143969,"median":10.575882,"eighty":12.606539,"marketCap":15828106723},{"date":"2022-06-24","current":8.408197,"twenty":7.145307,"median":9.539707,"eighty":12.573046,"marketCap":16291487352},{"date":"2022-06-30","current":7.86791,"twenty":7.173248,"median":8.407756,"eighty":12.549045,"marketCap":15218395370},{"date":"2022-07-08","current":7.708668,"twenty":7.192307,"median":8.255051,"eighty":12.514413,"marketCap":14925733921},{"date":"2022-07-15","current":7.119666,"twenty":7.192049,"median":8.186646,"eighty":12.444606,"marketCap":13657534307},{"date":"2022-07-22","current":7.292873,"twenty":7.192558,"median":8.134372,"eighty":12.408122,"marketCap":13998972664},{"date":"2022-07-29","current":6.624114,"twenty":7.143849,"median":8.058514,"eighty":12.394805,"marketCap":12730773050},{"date":"2022-08-05","current":6.679196,"twenty":7.108037,"median":8.01541,"eighty":12.344059,"marketCap":12803938413},{"date":"2022-08-12","current":6.746336,"twenty":7.015964,"median":7.902917,"eighty":12.241829,"marketCap":12950269137},{"date":"2022-08-19","current":6.506545,"twenty":6.904437,"median":7.849319,"eighty":12.101006,"marketCap":12364946238},{"date":"2022-08-26","current":6.444966,"twenty":6.85354,"median":7.765995,"eighty":12.021144,"marketCap":12560053871},{"date":"2022-09-02","current":6.75706,"twenty":6.802523,"median":7.70872,"eighty":11.996437,"marketCap":13120988316},{"date":"2022-09-09","current":7.186325,"twenty":6.782371,"median":7.676298,"eighty":11.956637,"marketCap":13901418848},{"date":"2022-09-16","current":7.037021,"twenty":6.773934,"median":7.658948,"eighty":11.933229,"marketCap":13486815128},{"date":"2022-09-23","current":7.278546,"twenty":6.801431,"median":7.629045,"eighty":11.919853,"marketCap":13681922761},{"date":"2022-09-30","current":7.21287,"twenty":6.812093,"median":7.563431,"eighty":11.90371,"marketCap":13584368944},{"date":"2022-10-07","current":8.495359,"twenty":6.827071,"median":7.601693,"eighty":11.901476,"marketCap":15998825902},{"date":"2022-10-14","current":7.866533,"twenty":6.84454,"median":7.6518,"eighty":11.887944,"marketCap":14657460926},{"date":"2022-10-21","current":7.65719,"twenty":6.852519,"median":7.654495,"eighty":11.837793,"marketCap":14169691843},{"date":"2022-10-28","current":7.485499,"twenty":6.854712,"median":7.648155,"eighty":11.810799,"marketCap":13828253486},{"date":"2022-11-04","current":7.71408,"twenty":6.855543,"median":7.64924,"eighty":11.777288,"marketCap":14389187930},{"date":"2022-11-11","current":9.447275,"twenty":6.857645,"median":7.65719,"eighty":11.716902,"marketCap":17779183053},{"date":"2022-11-18","current":8.946595,"twenty":6.869919,"median":7.676298,"eighty":11.61846,"marketCap":16779256434},{"date":"2022-11-25","current":10.591073,"twenty":6.900487,"median":7.708668,"eighty":11.56686,"marketCap":19705870928},{"date":"2022-12-02","current":10.475811,"twenty":6.903866,"median":7.7222,"eighty":11.486108,"marketCap":19827813199},{"date":"2022-12-09","current":10.787939,"twenty":6.908551,"median":7.756461,"eighty":11.467515,"marketCap":20608243731},{"date":"2022-12-16","current":10.467652,"twenty":6.922758,"median":7.825152,"eighty":11.433045,"marketCap":19949755470},{"date":"2022-12-23","current":10.605113,"twenty":6.925733,"median":7.866533,"eighty":11.416934,"marketCap":20218028465},{"date":"2022-12-30","current":10.490454,"twenty":6.934226,"median":7.88468,"eighty":11.373326,"marketCap":20242416919},{"date":"2023-01-06","current":10.709162,"twenty":6.946262,"median":7.911832,"eighty":11.346989,"marketCap":20876730726},{"date":"2023-01-13","current":10.409987,"twenty":6.967625,"median":7.940898,"eighty":11.310014,"marketCap":20681621093},{"date":"2023-01-20","current":10.970611,"twenty":6.992171,"median":8.025256,"eighty":11.115951,"marketCap":21608391850},{"date":"2023-01-27","current":11.178822,"twenty":7.001767,"median":8.04566,"eighty":11.178822,"marketCap":22022999820},{"date":"2023-02-03","current":10.333228,"twenty":7.00883,"median":8.080352,"eighty":11.042599,"marketCap":20462542256},{"date":"2023-02-10","current":10.432866,"twenty":7.016354,"median":8.128802,"eighty":10.999512,"marketCap":20535709869},{"date":"2023-02-17","current":10.482453,"twenty":7.02072,"median":8.154322,"eighty":10.970611,"marketCap":20438153052},{"date":"2023-02-24","current":10.422238,"twenty":7.023227,"median":8.186646,"eighty":10.901364,"marketCap":20072314990},{"date":"2023-03-03","current":10.103813,"twenty":7.024374,"median":8.255051,"eighty":10.877939,"marketCap":19584530908},{"date":"2023-03-10","current":9.849365,"twenty":9.829083,"median":9.880019,"eighty":9.959262,"marketCap":18950411601},{"date":"2023-03-17","current":10.294831,"twenty":10.851941,"median":19.048443,"eighty":26.326687,"marketCap":19999147378},{"date":"2023-03-24","current":8.629709,"twenty":10.789936,"median":18.976613,"eighty":26.218311,"marketCap":19023579213},{"date":"2023-03-31","current":8.718432,"twenty":10.730721,"median":18.809149,"eighty":26.129947,"marketCap":19072357621},{"date":"2023-04-06","current":8.880244,"twenty":10.716567,"median":18.692825,"eighty":26.082958,"marketCap":19413806479},{"date":"2023-04-14","current":9.049805,"twenty":10.697852,"median":18.558662,"eighty":26.015238,"marketCap":19804033745},{"date":"2023-04-21","current":8.753391,"twenty":10.627861,"median":18.432989,"eighty":25.943189,"marketCap":19145525234},{"date":"2023-04-28","current":8.819057,"twenty":10.598903,"median":18.271485,"eighty":25.849308,"marketCap":19145525234},{"date":"2023-05-05","current":8.835413,"twenty":10.581949,"median":18.06906,"eighty":25.740696,"marketCap":19212487419},{"date":"2023-05-12","current":8.252473,"twenty":10.520288,"median":17.98145,"eighty":25.676606,"marketCap":17821321039},{"date":"2023-05-19","current":8.651806,"twenty":10.481672,"median":17.862157,"eighty":25.617372,"marketCap":18420961720},{"date":"2023-05-25","current":9.128719,"twenty":10.4573,"median":17.786098,"eighty":25.551849,"marketCap":19356401182},{"date":"2023-06-02","current":8.88737,"twenty":10.414887,"median":17.743633,"eighty":25.442824,"marketCap":18780746128},{"date":"2023-06-09","current":8.684241,"twenty":10.379693,"median":17.593173,"eighty":25.321673,"marketCap":18325019211},{"date":"2023-06-16","current":8.497602,"twenty":10.298226,"median":17.536423,"eighty":25.234525,"marketCap":17845306666},{"date":"2023-06-23","current":8.314521,"twenty":10.235267,"median":17.466007,"eighty":25.17103,"marketCap":17365594121},{"date":"2023-06-30","current":9.120524,"twenty":10.102258,"median":17.164588,"eighty":25.018734,"marketCap":18876688637},{"date":"2023-07-07","current":8.464877,"twenty":10.024021,"median":16.874069,"eighty":24.903693,"marketCap":17485522257},{"date":"2023-07-14","current":8.313385,"twenty":9.8931,"median":16.779243,"eighty":24.834872,"marketCap":17413565376},{"date":"2023-07-21","current":8.50176,"twenty":9.81238,"median":16.464583,"eighty":24.737115,"marketCap":17725378530},{"date":"2023-07-28","current":8.672104,"twenty":9.353435,"median":16.177564,"eighty":24.675112,"marketCap":18061177311},{"date":"2023-08-04","current":8.358775,"twenty":9.161002,"median":15.883244,"eighty":24.577585,"marketCap":17437551003},{"date":"2023-08-11","current":8.117166,"twenty":9.070765,"median":15.513441,"eighty":24.497368,"marketCap":16837910322},{"date":"2023-08-18","current":7.942776,"twenty":9.010529,"median":15.366608,"eighty":24.346619,"marketCap":16358197777},{"date":"2023-08-25","current":7.720715,"twenty":8.968684,"median":15.291628,"eighty":24.251918,"marketCap":16022398996},{"date":"2023-09-01","current":7.55067,"twenty":8.931187,"median":15.199326,"eighty":24.160656,"marketCap":15734571469},{"date":"2023-09-08","current":7.780387,"twenty":8.882813,"median":14.999167,"eighty":24.077684,"marketCap":16022398996},{"date":"2023-09-15","current":8.044139,"twenty":8.832795,"median":14.893474,"eighty":24.001187,"marketCap":16693996559},{"date":"2023-09-22","current":7.800863,"twenty":8.805502,"median":14.827905,"eighty":23.891521,"marketCap":16118341505},{"date":"2023-09-29","current":7.590502,"twenty":8.767962,"median":14.58488,"eighty":23.787271,"marketCap":15710585842},{"date":"2023-10-06","current":7.594139,"twenty":8.732701,"median":14.497234,"eighty":23.749161,"marketCap":15710585842},{"date":"2023-10-13","current":7.802894,"twenty":8.680502,"median":14.383763,"eighty":23.669452,"marketCap":16118341505},{"date":"2023-10-20","current":7.396278,"twenty":8.651836,"median":14.296719,"eighty":23.61072,"marketCap":15254858924},{"date":"2023-10-27","current":7.620505,"twenty":8.636311,"median":14.231462,"eighty":23.563756,"marketCap":15710585842},{"date":"2023-11-03","current":8.238519,"twenty":8.593268,"median":14.135835,"eighty":23.541685,"marketCap":17029795340},{"date":"2023-11-10","current":8.135787,"twenty":8.561489,"median":14.026244,"eighty":23.507495,"marketCap":16813924695},{"date":"2023-11-17","current":8.155085,"twenty":8.521038,"median":13.963498,"eighty":23.459416,"marketCap":17005809713},{"date":"2023-11-24","current":8.53342,"twenty":8.497153,"median":13.860523,"eighty":23.39518,"marketCap":17941249175},{"date":"2023-12-01","current":8.532266,"twenty":8.455902,"median":13.824815,"eighty":23.33521,"marketCap":18013206057},{"date":"2023-12-08","current":8.167635,"twenty":8.416427,"median":13.708813,"eighty":23.268697,"marketCap":17173709103},{"date":"2023-12-15","current":8.120741,"twenty":8.372891,"median":13.573597,"eighty":23.268697,"marketCap":17173709103},{"date":"2023-12-22","current":7.547349,"twenty":8.340139,"median":13.445935,"eighty":23.268697,"marketCap":15950442114},{"date":"2023-12-29","current":8.489483,"twenty":8.333442,"median":13.401057,"eighty":23.268697,"marketCap":18037191684},{"date":"2024-01-05","current":7.958572,"twenty":8.311899,"median":13.353915,"eighty":23.268697,"marketCap":16789939068},{"date":"2024-01-12","current":7.522531,"twenty":8.274788,"median":13.298043,"eighty":23.268697,"marketCap":15878485232},{"date":"2024-01-19","current":6.838761,"twenty":8.246837,"median":13.193339,"eighty":23.218433,"marketCap":14415361971},{"date":"2024-01-26","current":6.751245,"twenty":8.199921,"median":13.152876,"eighty":23.153426,"marketCap":14175505698},{"date":"2024-02-02","current":6.645484,"twenty":8.178106,"median":13.103765,"eighty":23.113627,"marketCap":13935649426},{"date":"2024-02-09","current":6.464952,"twenty":8.160603,"median":13.048718,"eighty":23.081073,"marketCap":13623836272},{"date":"2024-02-16","current":6.270103,"twenty":8.153092,"median":12.964057,"eighty":23.031568,"marketCap":13216080609},{"date":"2024-02-23","current":6.154614,"twenty":8.12992,"median":12.866288,"eighty":22.958247,"marketCap":12904267455},{"date":"2024-03-01","current":6.425162,"twenty":8.119907,"median":12.768824,"eighty":22.855959,"marketCap":13479922508},{"date":"2024-03-08","current":5.668086,"twenty":8.106269,"median":12.685187,"eighty":22.664212,"marketCap":11896871111},{"date":"2024-03-15","current":5.970488,"twenty":8.087,"median":12.56608,"eighty":22.617544,"marketCap":12520497419},{"date":"2024-03-22","current":6.800223,"twenty":8.057136,"median":12.488798,"eighty":22.572752,"marketCap":14247462580},{"date":"2024-03-28","current":6.865119,"twenty":8.03691,"median":12.408404,"eighty":22.491655,"marketCap":14337425089},{"date":"2024-04-05","current":6.930569,"twenty":8.010866,"median":12.314157,"eighty":22.381231,"marketCap":14464581272},{"date":"2024-04-12","current":8.487739,"twenty":7.986804,"median":12.230754,"eighty":22.341312,"marketCap":14238321582},{"date":"2024-04-19","current":7.902573,"twenty":7.973424,"median":12.09409,"eighty":22.231233,"marketCap":13245377965},{"date":"2024-04-26","current":8.651786,"twenty":7.971703,"median":12.040613,"eighty":22.147797,"marketCap":14483242321},{"date":"2024-05-03","current":9.683032,"twenty":7.971703,"median":12.008496,"eighty":22.084093,"marketCap":16198363123},{"date":"2024-05-10","current":9.574862,"twenty":7.971703,"median":11.96006,"eighty":21.996434,"marketCap":16055436389},{"date":"2024-05-17","current":9.031812,"twenty":7.971703,"median":11.9246,"eighty":21.943927,"marketCap":15122602622},{"date":"2024-05-24","current":8.723102,"twenty":7.971703,"median":11.884599,"eighty":21.824145,"marketCap":14572351730},{"date":"2024-05-31","current":8.683193,"twenty":7.971703,"median":11.86257,"eighty":21.670633,"marketCap":14520444416},{"date":"2024-06-07","current":8.98585,"twenty":7.971703,"median":11.808963,"eighty":21.649887,"marketCap":15007926263},{"date":"2024-06-14","current":8.927337,"twenty":7.971703,"median":11.78311,"eighty":21.558611,"marketCap":14896537014},{"date":"2024-06-21","current":8.653958,"twenty":7.971703,"median":11.748959,"eighty":21.341418,"marketCap":14410135834},{"date":"2024-06-28","current":9.147662,"twenty":7.971703,"median":11.696048,"eighty":21.190941,"marketCap":15225906682},{"date":"2024-07-05","current":9.12874,"twenty":7.971703,"median":11.667775,"eighty":21.154306,"marketCap":15191112394},{"date":"2024-07-12","current":9.553452,"twenty":7.971703,"median":11.586418,"eighty":21.030296,"marketCap":15921227874},{"date":"2024-07-19","current":9.270632,"twenty":7.971703,"median":11.512821,"eighty":20.905813,"marketCap":15450185629},{"date":"2024-07-26","current":8.673146,"twenty":7.971703,"median":11.447067,"eighty":20.788718,"marketCap":14508131939},{"date":"2024-08-02","current":8.63594,"twenty":7.971703,"median":11.35879,"eighty":20.681196,"marketCap":14437475453},{"date":"2024-08-09","current":8.676727,"twenty":7.971703,"median":11.316787,"eighty":20.443888,"marketCap":14602340588},{"date":"2024-08-16","current":9.093035,"twenty":7.971703,"median":11.187378,"eighty":20.269083,"marketCap":15308905456},{"date":"2024-08-23","current":7.455797,"twenty":7.968286,"median":11.053511,"eighty":19.744503,"marketCap":13495388963},{"date":"2024-08-30","current":7.832605,"twenty":7.94319,"median":10.97804,"eighty":19.603864,"marketCap":14272610317},{"date":"2024-09-06","current":7.54462,"twenty":7.922419,"median":10.903863,"eighty":19.431,"marketCap":13754462748},{"date":"2024-09-13","current":7.305365,"twenty":7.904466,"median":10.877939,"eighty":19.216074,"marketCap":13283419503},{"date":"2024-09-20","current":7.339071,"twenty":7.881443,"median":10.812901,"eighty":19.042838,"marketCap":13424732476},{"date":"2024-09-27","current":8.203896,"twenty":7.851675,"median":10.750241,"eighty":18.92333,"marketCap":15096935995},{"date":"2024-10-04","current":9.501316,"twenty":7.851675,"median":10.719171,"eighty":18.804822,"marketCap":17405047895},{"date":"2024-10-10","current":8.812673,"twenty":7.854647,"median":10.700045,"eighty":18.679274,"marketCap":16039022485},{"date":"2024-10-18","current":8.416572,"twenty":7.851675,"median":10.633669,"eighty":18.484377,"marketCap":15238248969},{"date":"2024-10-25","current":8.130899,"twenty":7.851675,"median":10.60446,"eighty":18.375861,"marketCap":14720101400},{"date":"2024-11-01","current":7.618395,"twenty":7.837145,"median":10.583466,"eighty":18.158058,"marketCap":13801567072},{"date":"2024-11-08","current":7.940429,"twenty":7.812932,"median":10.521849,"eighty":18.004775,"marketCap":14319714641},{"date":"2024-11-15","current":7.616222,"twenty":7.800863,"median":10.481803,"eighty":17.930901,"marketCap":13589597612},{"date":"2024-11-22","current":7.289682,"twenty":7.7868,"median":10.43732,"eighty":17.787791,"marketCap":13000793556},{"date":"2024-11-29","current":7.558871,"twenty":7.756696,"median":10.406034,"eighty":17.75516,"marketCap":13471836801},{"date":"2024-12-06","current":8.19928,"twenty":7.756461,"median":10.371434,"eighty":17.593173,"marketCap":14578788426},{"date":"2024-12-13","current":8.162406,"twenty":7.756461,"median":10.287916,"eighty":17.536423,"marketCap":14484579777},{"date":"2024-12-20","current":8.065423,"twenty":7.756461,"median":10.197205,"eighty":17.447722,"marketCap":14249058155},{"date":"2024-12-27","current":7.911585,"twenty":7.756461,"median":10.12095,"eighty":17.361184,"marketCap":13966432208},{"date":"2025-01-03","current":7.87719,"twenty":7.756461,"median":10.036539,"eighty":16.928768,"marketCap":13919327883},{"date":"2025-01-10","current":7.612806,"twenty":7.740892,"median":10.004547,"eighty":16.790663,"marketCap":13401180314},{"date":"2025-01-17","current":8.28846,"twenty":7.730321,"median":9.838221,"eighty":16.516863,"marketCap":14602340588},{"date":"2025-01-24","current":8.157137,"twenty":7.730321,"median":9.650996,"eighty":16.380162,"marketCap":14461027615},{"date":"2025-01-28","current":7.942804,"twenty":7.731645,"median":9.603098,"eighty":16.23971,"marketCap":14154849506},{"date":"2025-02-07","current":8.546227,"twenty":7.72951,"median":9.447275,"eighty":15.827107,"marketCap":15144040320},{"date":"2025-02-14","current":8.966376,"twenty":7.72951,"median":9.349312,"eighty":15.479298,"marketCap":15850605187},{"date":"2025-02-21","current":9.142724,"twenty":7.72951,"median":9.31673,"eighty":15.341254,"marketCap":16250991945},{"date":"2025-02-28","current":9.757898,"twenty":7.72951,"median":9.275627,"eighty":15.286311,"marketCap":17287287084},{"date":"2025-03-07","current":10.023419,"twenty":7.728699,"median":9.273129,"eighty":15.091756,"marketCap":17828986815},{"date":"2025-03-14","current":12.825839,"twenty":7.728699,"median":9.273129,"eighty":14.95492,"marketCap":22822045210},{"date":"2025-03-21","current":13.665083,"twenty":7.728699,"median":9.273129,"eighty":14.886108,"marketCap":24305831431},{"date":"2025-03-28","current":12.928275,"twenty":7.728699,"median":9.273129,"eighty":14.825099,"marketCap":28922055230},{"date":"2025-04-03","current":13.892013,"twenty":7.728699,"median":9.273129,"eighty":14.555799,"marketCap":31088854156},{"date":"2025-04-11","current":13.167923,"twenty":7.728699,"median":9.273129,"eighty":14.420765,"marketCap":29204681177},{"date":"2025-04-17","current":12.670277,"twenty":7.72951,"median":9.275627,"eighty":14.377837,"marketCap":28168386039},{"date":"2025-04-25","current":13.794908,"twenty":7.727888,"median":9.270632,"eighty":14.256721,"marketCap":30695134656},{"date":"2025-05-02","current":14.188557,"twenty":7.728699,"median":9.273129,"eighty":14.229301,"marketCap":31638149546},{"date":"2025-05-09","current":12.682782,"twenty":7.727888,"median":9.270632,"eighty":14.162597,"marketCap":28479049665},{"date":"2025-05-16","current":13.271183,"twenty":7.727888,"median":9.270632,"eighty":14.052194,"marketCap":30043763873},{"date":"2025-05-23","current":20.823678,"twenty":7.727888,"median":9.270632,"eighty":14.052194,"marketCap":47282375641},{"date":"2025-05-30","current":19.460658,"twenty":7.727888,"median":9.270632,"eighty":14.052194,"marketCap":44381761075},{"date":"2025-06-06","current":20.841619,"twenty":7.727888,"median":9.270632,"eighty":14.052194,"marketCap":47652430724},{"date":"2025-06-13","current":24.030584,"twenty":7.727888,"median":9.270632,"eighty":14.052194,"marketCap":54965427519},{"date":"2025-06-20","current":21.494325,"twenty":7.727888,"median":9.270632,"eighty":14.052194,"marketCap":49067849459},{"date":"2025-06-27","current":23.392241,"twenty":7.728699,"median":9.273129,"eighty":14.074787,"marketCap":53550008784}],"updateTime":1751073441379}}}